ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SUN Surgical Innovations Group Plc

0.50
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.60 0.50 0.50 0.50 214,290 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 11.34M 264k 0.0003 16.67 4.66M
Surgical Innovations Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 0.50p. Over the last year, Surgical Innovations shares have traded in a share price range of 0.40p to 2.25p.

Surgical Innovations currently has 932,816,000 shares in issue. The market capitalisation of Surgical Innovations is £4.66 million. Surgical Innovations has a price to earnings ratio (PE ratio) of 16.67.

Surgical Innovations Share Discussion Threads

Showing 11726 to 11748 of 11925 messages
Chat Pages: 477  476  475  474  473  472  471  470  469  468  467  466  Older
DateSubjectAuthorDiscuss
29/3/2022
21:39
POST REMOVED
buywell2
24/3/2022
08:09
POST REMOVED
buywell2
24/3/2022
05:57
POST REMOVED
buywell2
24/3/2022
02:17
POST REMOVED
buywell2
23/3/2022
07:19
POST REMOVED
buywell2
21/3/2022
21:45
POST REMOVED
buywell2
21/3/2022
15:42
POST REMOVED
buywell2
21/3/2022
10:05
I was drawn to this by todays rns. Surprisingly little trade
hybrasil
21/3/2022
07:48
POST REMOVED
buywell2
20/3/2022
21:25
POST REMOVED
buywell2
16/3/2022
22:01
POST REMOVED
buywell2
10/3/2022
00:45
POST REMOVED
buywell2
09/3/2022
03:57
POST REMOVED
buywell2
08/3/2022
22:36
POST REMOVED
buywell2
19/1/2022
03:31
Outlook on the Minimally Invasive Surgical Instruments Global Market to 2028 - Increasing Prevalence of Chronic Diseases are Driving Growth


The global minimally invasive surgical instruments market size is estimated to reach USD $51.49 Billion by 2028 with a CAGR 14.5%

The handheld MIS surgical instrument segment accounted for the largest revenue share in 2020 due to high demand on account of benefits, such as improved recovery time and reduced side effects

Collaborative strategies have been undertaken by leaders in the market and constant updates & launches of new products have improved the market.

Which experienced a dip during 2020 due to the COVID-19 pandemic.

Reduction in elective and planned surgeries by nearly 50% has declined the market dramatically in 2020 through to 2021 which were further exacerbated by restrictions on logistic movement, disturbed raw material supplies, and the economic instability of hospitals together with staffing problems and sickness.

The Minimally Invasive Surgery (MIS) market is now said to stabilize by early 2022 as the Omicron wave subsides.

Surgical Innovations ( Elemental Healthcare) operate entirely within this growth market

Which IMO explains the huge list of well known Institutional Investor that are currently invested in SUN

In 2020 a study titled :

The Rise of Minimally Invasive Surgery: 16 Year Analysis of the Progressive Replacement of Open Surgery with Laparoscopy

Concluded


'While the overall operative volume has increased nationally for surgical residents, the representation of open cases has steadily declined since the advent of MIS. The experience needed in open surgery during resident training is still to be determined and may be necessary now that laparoscopy is progressively replacing open operations.'




Hence the uptake of Reposable MIS surgical instruments seems assured as it reduces NHS costs --- plus it helps meet NHS plastic waste reduction targets

Which is why CEO David Marsh in the trading update said:

"While we anticipate that first quarter sales may reduce down to 80 per cent of pre-pandemic levels, we do however expect a return to normalised hospital activity in the second quarter and see prospects for improved momentum in the second half."

"Overall, we anticipate that annualised sales by year end 2022 will exceed the level of revenue in 2019 as a pre-pandemic benchmark. This reflects anticipated progress on the adoption of our innovative Resposable technology to reduce waste and cost in elective surgery.”

imo dyor

buywell3
18/1/2022
22:09
POST REMOVED
buywell3
17/1/2022
21:25
POST REMOVED
buywell3
17/1/2022
07:24
POST REMOVED
buywell3
05/12/2021
08:32
And yet more evidence for the BUYWRONGS

Sunday Times today

"Doctors and nurses have told of their anger and frustration at not being able to treat seriously ill patients as new figures show that more than 90 per cent of Covid sufferers requiring the most specialist care are unvaccinated. While the success of the vaccination rollout has reduced the overall...

pugugly
03/12/2021
11:22
ditto re Buywells 1 2 & 3 - A real poumper and dumper -
I have no intention on givening you access to the brokers notes etc that I receive. Hence comment re press rather than details of BNs'[

pugugly
03/12/2021
09:20
POST REMOVED
buywell2
03/12/2021
09:16
buywell2 - re 133 - Read the press -
pugugly
03/12/2021
09:13
POST REMOVED
buywell2
Chat Pages: 477  476  475  474  473  472  471  470  469  468  467  466  Older

Your Recent History

Delayed Upgrade Clock